US Patent Family Members and Approved Drugs for Taiwan Patent: I557228
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Taiwan Patent: TWI557228
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 9,062,106 | 2032-04-26 | adalimumab | Abbvie Inc. | HUMIRA |
| 9,090,688 | 2032-04-26 | adalimumab | Abbvie Inc. | HUMIRA |
| 9,505,834 | 2032-04-26 | adalimumab | Abbvie Inc. | HUMIRA |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
